| 【Company Research】INT Medical (1501 HK) - Solid earnings amid challenging business environment |
| 【Company Research】Xtep (1368 HK) - Stay prudent as channel health is the priority |
| 【Sector Research】Property - 2M24 NBS data: Piling up inventory with poor sales, hope lies in Mar |
| 【Company Research】GigaCloud (GCT US) - Riding on stepping-up of expansion |
| 【公司研究】华润啤酒 (291 HK) – 全年派息比例59%，啤酒高端化趋势不变，白酒稳步发展 |
| 【Sector Research】Internet - 2M24 online retail sales recap |
| 【Company Research】Kelun-Biotech (6990 HK) - MSD has further expedited global clinical development of SKB264 |
| 【行业研究】中国医药 - 海外医疗器械行业2023年度业绩剖析：手术市场强劲复苏，设备采购需求逐渐改善 |
| 【行业研究】中国医药 - 期待创新支持政策落地 |
| 【Company Research】Shennan Circuit (002916 CH) - FY23 results beat helped by better 4Q |
Address: 45th & 46th Floor, Champion Tower, 3 Garden Road, Central, Hong Kong
Telephone: （852）3900 0888 Fax:（852）3761 8788
Copyright © 2019-2026 CMB International Capital Corporation Limited. All rights reserved.
